Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 2 (2005), Issue 1 (January)

1. Analysis of subcarinal lymph nodes in (suspected) non-small-cell lung cancer after a negative transbronchial needle aspiration -- what's next? A preliminary report.
   Respiration, 71(6): 630-4. [Abstract] [Full-text]
2. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets.
   Int J Radiat Oncol Biol Phys, 61(1): 239-49. [Abstract] [Full-text]
3. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
   Int J Radiat Oncol Biol Phys, 61(1): 70-5. [Abstract] [Full-text]
4. Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
   Int J Radiat Oncol Biol Phys, 61(1): 64-9. [Abstract] [Full-text]
5. Willingness to pay for low-lung-cancer-risk cigarettes in Taiwan.
   Health Econ, 14(1): 55-67. [Abstract] [Full-text]
6. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach.
   Mod Pathol, 18(1): 111-8. [Abstract] [Full-text]
7. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
   J Thorac Cardiovasc Surg, 129(1): 87-93. [Abstract] [Full-text]
8. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
   J Thorac Cardiovasc Surg, 129(1): 64-72. [Abstract] [Full-text]
9. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
   J Natl Cancer Inst, 97(1): 59-69. [Abstract] [Full-text]
10. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
    Oncologist, 10(1): 22-33. [Abstract] [Full-text]
11. Remote intrapulmonary spread of recurrent respiratory papillomatosis with malignant transformation.
    Pediatr Pulmonol, 39(2): 185-8. [Abstract] [Full-text]
12. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect.
    Jpn J Clin Oncol, 34(12): 717-21. [Abstract] [Full-text]
13. Percutaneous placement of marking coils before stereotactic radiation therapy of malignant lung lesions.
    J Vasc Interv Radiol, 16(1): 51-6. [Abstract] [Full-text]
14. Bronchioloalveolar carcinoma: a new cancer in Peutz-Jeghers syndrome.
    Lung Cancer, 47(2): 283-8. [Abstract] [Full-text]
15. Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.
    Lung Cancer, 47(2): 269-75. [Abstract] [Full-text]
16. Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study.
    Lung Cancer, 47(2): 261-7. [Abstract] [Full-text]
17. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.
    Lung Cancer, 47(2): 253-9. [Abstract] [Full-text]
18. Surgical mediastinal staging in daily practice.
    Lung Cancer, 47(2): 243-51. [Abstract] [Full-text]
19. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
    Lung Cancer, 47(2): 235-42. [Abstract] [Full-text]
20. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
    Lung Cancer, 47(2): 225-33. [Abstract] [Full-text]
21. Anticoagulant drugs increase natural killer cell activity in lung cancer.
    Lung Cancer, 47(2): 215-23. [Abstract] [Full-text]
22. Lung carcinoma-associated atypical adenomatoid hyperplasia, squamous cell dysplasia, and chromosome alterations in non-neoplastic bronchial mucosa.
    Lung Cancer, 47(2): 205-14. [Abstract] [Full-text]
23. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.
    Lung Cancer, 47(2): 193-204. [Abstract] [Full-text]
24. Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance.
    Lung Cancer, 47(2): 183-92. [Abstract] [Full-text]
25. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years.
    Lung Cancer, 47(2): 173-81. [Abstract] [Full-text]
26. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women.
    Lung Cancer, 47(2): 165-72. [Abstract] [Full-text]
27. Lung cancer in an urban area in Northern Italy near a coke oven plant.
    Lung Cancer, 47(2): 155-64. [Abstract] [Full-text]
28. Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography.
    Am J Respir Crit Care Med, 171(2): 177-82. [Abstract] [Full-text]
29. Primary desmoplastic small round cell tumor of bone: report of a case with cytogenetic confirmation.
    Cancer Genet Cytogenet, 156(2): 167-71. [Abstract] [Full-text]
30. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
    Environ Mol Mutagen, 45(1): 17-35. [Abstract] [Full-text]
31. Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
    J Biol Chem, 280(2): 1103-11. [Abstract] [Full-text]
32. Studies of radon-exposed miner cohorts using a biologically based model: comparison of current Czech and French data with historic data from China and Colorado.
    Radiat Environ Biophys, 43(4): 247-56. [Abstract] [Full-text]
33. Patient with immunoproliferative disease and lung carcinoma: a case report.
    Diagn Cytopathol, 32(2): 97-102. [Abstract] [Full-text]
34. Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT.
    Eur Radiol, 15(1): 14-22. [Abstract] [Full-text]
35. Papillary thyroid carcinomas with lung metastases.
    Thyroid, 14(12): 1091-6. [Abstract] [Full-text]
36. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.
    Ann N Y Acad Sci, 1028: 351-60. [Abstract] [Full-text]
37. Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays.
    Nucleic Acids Res, 33(1): 409-21. [Abstract] [Full-text]
38. Asthma, the ugly duckling of lung disease proteomics?
    J Chromatogr B Analyt Technol Biomed Life Sci, 815(1): 285-94. [Abstract] [Full-text]
39. Origins and selection of p53 mutations in lung carcinogenesis.
    Semin Cancer Biol, 15(2): 103-12. [Abstract] [Full-text]
40. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
    J Neuroimmunol, 159(1): 230-7. [Abstract] [Full-text]
41. High-resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines.
    Genes Chromosomes Cancer, 42(3): 308-13. [Abstract] [Full-text]
42. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer.
    Cancer, 103(2): 377-82. [Abstract] [Full-text]
43. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.
    Mol Cell Biol, 25(3): 1054-69. [Abstract] [Full-text]
44. Effect of different approaches to treatment of smoking as a potential confounder in a case-control study on occupational exposures.
    Occup Environ Med, 62(2): 101-4. [Abstract] [Full-text]
45. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases.
    Histopathology, 46(1): 57-63. [Abstract] [Full-text]
46. Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity.
    Am J Respir Cell Mol Biol, 32(2): 135-41. [Abstract] [Full-text]
47. Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers.
    Am J Respir Cell Mol Biol, 32(2): 142-8. [Abstract] [Full-text]
48. Lung adenocarcinoma associated with familial adenomatous polyposis. Clear cell carcinoma with beta-catenin accumulation accompanied by atypical adenomatous hyperplasia.
    Virchows Arch, 446(1): 73-7. [Abstract] [Full-text]
49. Lithotripter shockwave-induced enhancement of mouse melanoma lung metastasis: dependence on cavitation nucleation.
    J Endourol, 18(9): 925-9. [Abstract] [Full-text]
50. Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study.
    J Clin Oncol, 23(3): 569-75. [Abstract] [Full-text]
51. Body mass index and the risk of male cancer mortality of various sites: 17-year follow-up of the Basel cohort study.
    Swiss Med Wkly, 135(1): 27-33. [Abstract] [Full-text]
52. Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence.
    Eur J Cancer, 41(2): 306-12. [Abstract] [Full-text]
53. Small cell carcinoma of the prostate with hypercalcemia.
    Int J Urol, 12(1): 108-10. [Abstract] [Full-text]
54. Pulmonary tumor thrombotic microangiopathy caused by a gastric carcinoma expressing vascular endothelial growth factor and tissue factor.
    Pathol Int, 55(1): 27-31. [Abstract] [Full-text]
55. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
    Pathol Int, 55(1): 14-8. [Abstract] [Full-text]
56. Reproducibility of the diagnosis of small adenocarcinoma of the lung and usefulness of an educational program for the diagnostic criteria.
    Pathol Int, 55(1): 8-13. [Abstract] [Full-text]
57. Computer-assisted detection of pulmonary nodules: evaluation of diagnostic performance using an expert knowledge-based detection system with variable reconstruction slice thickness settings.
    Eur Radiol, 15(2): 203-12. [Abstract] [Full-text]
58. Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
    J Cancer Res Clin Oncol, 131(3): 147-51. [Abstract] [Full-text]
59. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
    Brain Behav Immun, 19(2): 114-26. [Abstract] [Full-text]
60. Computer-aided detection of pulmonary nodules: influence of nodule characteristics on detection performance.
    Clin Radiol, 60(2): 196-206. [Abstract] [Full-text]
61. Immuno-histochemical detection of MRPs in human lung cells in culture.
    Toxicology, 207(3): 437-50. [Abstract] [Full-text]
62. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population.
    Neurosci Lett, 374(3): 157-60. [Abstract] [Full-text]
63. Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China.
    Carcinogenesis, 26(2): 303-8. [Abstract] [Full-text]
64. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Carcinogenesis, 26(2): 429-40. [Abstract] [Full-text]
65. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.
    Carcinogenesis, 26(2): 293-301. [Abstract] [Full-text]
66. DNMT3B polymorphisms and risk of primary lung cancer.
    Carcinogenesis, 26(2): 403-9. [Abstract] [Full-text]
67. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
    Carcinogenesis, 26(2): 395-401. [Abstract] [Full-text]
68. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Carcinogenesis, 26(2): 481-6. [Abstract] [Full-text]
69. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
    Carcinogenesis, 26(2): 381-6. [Abstract] [Full-text]
70. Metachronous squamous cell carcinomas evolving from independent oropharyngeal and pulmonary squamous papillomas: association with human papillomavirus 11 and lack of aberrant p53, Rb, and p16 protein expression.
    Hum Pathol, 35(11): 1419-22. [Abstract] [Full-text]
71. Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer.
    Hum Pathol, 35(11): 1347-52. [Abstract] [Full-text]
72. Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial.
    Ann Oncol, 16(2): 294-9. [Abstract] [Full-text]
73. Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor.
    Mol Ther, 11(2): 311-9. [Abstract] [Full-text]
74. Nonrigid registration method to assess reproducibility of breath-holding with ABC in lung cancer.
    Int J Radiat Oncol Biol Phys, 61(2): 594-607. [Abstract] [Full-text]
75. Dosimetric and clinical predictors for radiation-induced esophageal injury.
    Int J Radiat Oncol Biol Phys, 61(2): 335-47. [Abstract] [Full-text]
76. Analysis of the movement of calcified lymph nodes during breathing.
    Int J Radiat Oncol Biol Phys, 61(2): 329-34. [Abstract] [Full-text]
77. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Int J Radiat Oncol Biol Phys, 61(2): 318-28. [Abstract] [Full-text]
78. Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa).
    Support Care Cancer, 13(1): 70-2. [Abstract] [Full-text]
79. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.
    Support Care Cancer, 13(1): 66-9. [Abstract] [Full-text]
80. Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial.
    Am J Epidemiol, 161(3): 260-70. [Abstract] [Full-text]
81. Lung cancer screening: simulations of effects of imperfect detection on temporal dynamics.
    Radiology, 234(2): 582-90. [Abstract] [Full-text]
82. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
    Biochem Biophys Res Commun, 328(1): 206-12. [Abstract] [Full-text]
83. Inhibitory effect of Boerhaavia diffusa on experimental metastasis by B16F10 melanoma in C57BL/6 mice.
    Life Sci, 76(12): 1339-49. [Abstract] [Full-text]
84. Obstipation as a paraneoplastic presentation of small cell lung cancer: case report and literature review.
    Neurogastroenterol Motil, 17(1): 16-22. [Abstract] [Full-text]
85. Metastatic lung and pleural malignancy presenting as bilateral acute anterior uveitis.
    Clin Experiment Ophthalmol, 33(1): 99-100. [Abstract] [Full-text]
86. Truck drivers and heart disease in the United States, 1979-1990.
    Am J Ind Med, 47(2): 113-9. [Abstract] [Full-text]
87. Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.
    Int J Cancer, 114(2): 219-23. [Abstract] [Full-text]
88. Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13.
    Int J Cancer, 114(1): 80-7. [Abstract] [Full-text]
89. Oxidative DNA damage and antioxidant vitamin level: comparison among lung cancer patients, healthy smokers and nonsmokers.
    Int J Cancer, 114(1): 153-6. [Abstract] [Full-text]
90. p53 autoantibodies predict subsequent development of cancer.
    Int J Cancer, 114(1): 157-60. [Abstract] [Full-text]
91. A hybrid protein of the amino-terminal fragment of urokinase and mutant plasminogen activator inhibitor-2 efficiently inhibits tumor cell invasion and metastasis.
    J Cancer Res Clin Oncol, 131(2): 129-36. [Abstract] [Full-text]
92. Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway.
    J Cell Biochem, 93(4): 819-29. [Abstract] [Full-text]
93. Early versus late chest radiotherapy for limited stage small cell lung cancer.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
94. Surgery for early stage non-small cell lung cancer.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
95. Small (</=2-cm) subpleural pulmonary lesions: short- versus long-needle-path CT-guided Biopsy--comparison of diagnostic yields and complications.
    Radiology, 234(2): 631-7. [Abstract] [Full-text]
96. Pleuropulmonary blastoma in childhood. A malignant degeneration of pulmonary cysts.
    Pediatr Surg Int, 20(11): 863-5. [Abstract] [Full-text]
97. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg, 129(2): 261-7. [Abstract] [Full-text]
98. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
    J Clin Pathol, 58(2): 202-6. [Abstract] [Full-text]
99. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies.
    BMJ, 330(7485): 223. [Abstract] [Full-text]
100. Multiple sclerosing hemangiomas with a 10-year history.
     Jpn J Clin Oncol, 35(1): 37-9. [Abstract] [Full-text]
101. Estimation of the time of pulmonary metastasis in colorectal cancer patients with isolated synchronous liver metastasis.
     Jpn J Clin Oncol, 35(1): 18-22. [Abstract] [Full-text]
102. Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.
     Jpn J Clin Oncol, 35(1): 6-12. [Abstract] [Full-text]
103. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
     J Clin Oncol, 23(4): 857-65. [Abstract] [Full-text]
104. Influence of sex on toxicity and treatment outcome in small-cell lung cancer.
     J Clin Oncol, 23(4): 850-6. [Abstract] [Full-text]
105. Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer.
     J Clin Oncol, 23(4): 842-9. [Abstract] [Full-text]
106. 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells.
     Arch Biochem Biophys, 435(1): 50-5. [Abstract] [Full-text]
107. Transthoracic endosonography for the intraoperative localization of lung nodules.
     Ann Thorac Surg, 79(2): 443-9; discussion 443-9. [Abstract] [Full-text]
108. Immediate and long-term survival after surgery for lung cancer in heart transplant recipients.
     Ann Thorac Surg, 79(2): 438-42. [Abstract] [Full-text]
109. Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer.
     BMC Cancer, 5(1): 1. [Abstract] [Full-text]

© 2004-2010 Lung Cancer Research Today. All Rights Reserved.